Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
M.D. Anderson Cancer Center AstraZeneca |
---|---|
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00688168 |
Objectives:
Condition | Intervention |
---|---|
Multiple Myeloma |
Behavioral: Questionnaire Behavioral: Phone Call Behavioral: Neurocognitive Testing Behavioral: Neurosensory Testing |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Identifying the Role of Inflammatory Cytokines in Symptom Production in Multiple Myeloma |
Estimated Enrollment: | 125 |
Study Start Date: | May 2008 |
Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
1
Patients diagnosed with multiple myeloma (MM).
|
Behavioral: Questionnaire
Questionnaires measuring pain and other symptoms, mood, and quality of life.
Behavioral: Phone Call
A telephone system will call 2 times a week for 12 weeks to rate your symptoms and how they may be interfering with daily activities.
Behavioral: Neurocognitive Testing
A neurocognitive exam (tests to check your memory and thinking abilities, for example) will be performed.
Behavioral: Neurosensory Testing
Neurosensory testing will be performed to find out how sensitive you are to things such as touch, coolness, warmth, pinprick on the finger, and squeezing of the skin on the finger, hand, or arm.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients diagnosed with multiple myeloma (MM).
Inclusion Criteria:
Exclusion Criteria:
Contact: Xin Shelley Wang, MD | 713-745-3470 |
United States, Texas | |
U.T.M.D. Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Principal Investigator: Xin Shelley Wang, MD |
Principal Investigator: | Xin Shelley Wang, MD | U.T.M.D. Anderson Cancer Center |
Responsible Party: | U.T.M.D. Anderson Cancer Center ( Xin Shelley Wang, MD/Associate Professor ) |
Study ID Numbers: | 2007-0612 |
Study First Received: | May 28, 2008 |
Last Updated: | January 5, 2009 |
ClinicalTrials.gov Identifier: | NCT00688168 |
Health Authority: | United States: Institutional Review Board |
Multiple Myeloma Phone Call Treatment Naive Inflammatory Cytokines Questionnaire Survey |
Interactive Voice Response Symptom Production Pain IVR MM |
Immunoproliferative Disorders Blood Protein Disorders Hematologic Diseases Blood Coagulation Disorders Vascular Diseases Pain Paraproteinemias |
Hemostatic Disorders Multiple Myeloma Hemorrhagic Disorders Multiple myeloma Lymphoproliferative Disorders Neoplasms, Plasma Cell |
Neoplasms Neoplasms by Histologic Type Immune System Diseases Cardiovascular Diseases |